Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 72INDUSTRY 10OTHER_GOV 3NIH 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1

Conditions

Pain 2Pleural Effusion, Malignant 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 385Specimen Handling 370Magnetic Resonance Spectroscopy 325Radiotherapy 306Biopsy 269Cisplatin 257Carboplatin 253Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 182Bevacizumab 180Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 140Taxes 127Docetaxel 122Oxaliplatin 113Chemotherapy, Adjuvant 113fludarabine phosphate 111Rituximab 107Methotrexate 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Interventional × Morphine × Clear all
NCT00378937 2013-08-02

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain

National Cancer Institute (NCI)

Phase 4 Completed
30 enrolled

Pain

NCT00020618 2013-07-18

Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain

National Cancer Institute (NCI)

Phase 2 Completed

Pain

NCT00644319 2009-07-08

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

National Cancer Institute (NCI)

Phase 2 Unknown
320 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡